CDC’s New Diagnosis Codes for Detransitioning Patients

Recent developments in American healthcare have marked a significant move toward justice, safety, and compassionate treatment. The Centers for Disease Control and Prevention (CDC) announced plans to officially recognize patients affected by gender-affirming care. This step addresses those resolving gender confusion and those reclaiming their biological gender after transitioning. The U.S. is leading the way globally in offering these individuals the recognition and healthcare they need.

Historically, when patients sought treatment for gender dysphoria or other medical issues, doctors documented visits using diagnosis codes. These codes identified the patient’s condition in the medical record, aiding in treatment planning, facilitating insurance billing, and providing data for medical research. However, until now, no codes existed for patients seeking to resolve discomfort with their biological gender or reverse an attempted sex change. Although codes for gender transition have been established since 2015, the medical system did not account for detransitioning efforts.

This oversight highlights a belief within some of the medical community that detransitioning is non-existent. The diagnosis system includes specific codes for even rare incidents, yet lacked codes for individuals regretting sex-change procedures. This absence denied medical recognition for those wishing to revert, undermining their need for adequate care.

Patients, including a woman in her twenties who underwent surgery to remove her ovaries, have suffered significantly. Attempting to revert to her female identity, she faced challenges due to the medical system treating her as male. This invisibility resulted in inappropriate hormone treatments and uncovered medical expenses. Her case exemplifies the growing need for recognition within the medical system.

Over 14,000 children have received sex-change treatments recently. As they mature, some may wish to reclaim their previous gender, necessitating hormone replacement and mental health support. Recognizing these patients is crucial for ensuring proper care. The CDC’s new codes, expected in October, will empower doctors to design effective treatment plans. They also allow researchers to gather real-world data, informing future medical advancements.

These developments enable American medicine to quantify how many individuals wish to reclaim their true gender, a figure previously obscured. Transparency has met resistance from transgender activists, who inaccurately depict detransitioners as a threat. Nonetheless, these patients should not face stigma for their medical conditions. They deserve compassionate and ethical care.

Guided by the CDC, the U.S. healthcare system sets an example for global practices. It aims to support detransitioners, enabling them to receive the healing and hope they require.

Dr. Aida Cerundolo is an emergency medicine physician and senior fellow at Do No Harm.